Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris

International Journal of STD and AIDS

Volumn 10, Issue 8, 1999, Pages 522-526

  Janier, M ^a   Lassau, F ^a   Bloch, J ^b   Spindler, E ^a   Morel, P ^a   Gerard P ^c   Aufrere A ^c  

^a SAINT LOUIS HOSPITAL   (France)

^b EVAL   (France)

^c Smithkline Beecham Laboratories   (France)

Author keywords

Genital herpes; Herpes simplex virus type 2; HSV 2 serology (EIA); STD

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; FRANCE; GENITAL HERPES; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COUNSELING; PRIORITY JOURNAL; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE;

EID: 0032767530     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991914609     Document Type: Article

References (30)

1. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-9
2. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770-5
3. Prober CG, Hensleigh PA, Boucher FD, Yasukawa LL, Au DS, Arvin AM. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med 1988;318:887-91
4. Keet IPM, Lee FK, Van Griensven GJP, Lange JMA, Nahmias A, Coutinho RA. Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourin Med 1990;66:330-3
5. Ashley RL, Dalessio J, Dragavon J, et al. Underestimation of HSV-2 seroprevalence in a high-risk population by microneutralization assay. Sex Transm Dis 1993;20:230-5
6. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States 1976 to 1994. N Engl J Med 1997;337:1105-11
7. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having 'asymptomatic' herpes simplex virus type 2 infection. Ann Intern Med 1989;110:882-7
8. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8-15
9. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989;321:7-12
10. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: Implications for STD epidemiology. Int J STD AIDS 1994;5:113-16
11. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburgh: Serologic, sexual and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990;162:299-305
12. Kulhanjian JA, Soroush V, Au DS, et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992;326:916-20
13. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9
14. Huerta K, Berkelhammer S, Klein J, Ammerman S, Chang J, Prober CG. Epidemiology of herpes simplex virus type 2 infections in a high-risk adolescent population. J Adolesc Health 1996;18:384-6
15. Cunningham AL, Lee FK, Ho DWT, et al. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med J Aust 1993;158:525-8
16. Wald A, Koutsky L, Ashley RL, Corey L. Genital herpes in a primary care clinic - Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997;24:149-55
17. Rosenthal SL, Stanberry LR, Biro FM, et al. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis 1997;24:135-9
18. Perkins NL, Coughlan EP, Franklin RA, Reid MR, Taylor J. Seroprevalence of herpes simplex vires type 2 antibodies in New Zealand sexual health clinic patients. NZ Med J 1996;109:402-5
19. Janier M, Spindler E, Schenmetzler C, et al. Etude de séroprévalence des marqueurs d'infections virales chez 610 patients consultant pour MST. Ann Dermatol Venereol 1995;122(Suppl):S127
20. Delem A, Gerard P, Cheysen D, Van Opstal O, Kangro H. Serotyping of HSV infections using recombinant gG1 and gG2. 37th Icaac, 28 September to 1 October 1997, Toronto, Ontario
21. Nahmias AJ, Lee FK, Beckman-Nahmias S. Seroepidemiological and serological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990;60(Suppl): 19-36
22. Lupi da Rosa-Santos O, Goncalves da Silva A, Pereira AC. Herpes simplex virus type 2 in Brazil: Seroepidemiologic survey. Int J Dermatol 1996;35:794-6
23. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202
24. Mertz GJ, Ashley R, Burke RL., et al. Double-blind placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J Infect Dis 1990;161:653-60
25. Rodgers CA, O'Mahony C. High prevalence of herpes simplex virus type I in female anogenital herpes simplex. Int J STD AIDS 1995;6:144
26. Christie SN, McCaughey C, McBride M, Coyle PV. Herpes simplex type 1 and genital herpes in Northern Ireland. Int J STD AIDS 1997;8:68-70
27. Shev S, Widell A, Bergström T, Hermodsson S, Lindholm A, Norkrans G. Herpes simplex virus 2 may increase susceptibility of the sexual transmission of hepatitis C. Sex Transm Dis 1995;22:210-16
28. Ashley RL, Corey L. HSV type specific antibody tests: Patients are ready, are clinicians? Sex Transm Dis 1997;73:235-6
29. Fairley I, Monteiro EF. Patient attitudes to type specific serological tests in the diagnosis of genital herpes. Genitourin Med 1997;73:259-62
30. Wasserheit JN. Epidemiological synergy: Interrelationship between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-7